SCHEMBL2121970

SCHEMBL2121970

CC(=CCCC[Si](O[Si](C)(C)C)(O[Si](C)(C)C)O[Si](C)(C)C)C(N)=O

nearest known ligand 0.31

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
MAPT P10636 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2474722 0.85 TDP1 (0.33)
SCHEMBL809437 0.85 TBXAS1 (0.33)
SCHEMBL400292 0.85 TBXAS1 (0.33)
SCHEMBL9244224 0.84
SCHEMBL17455444 0.83 ALDH1A1 (0.34) ALDH1A1CYP3A4CYP2D6MAPTCYP2C19
SCHEMBL3796636 0.83 ALDH1A1 (0.34) ALDH1A1CYP3A4CYP2D6MAPTCYP2C19
Acrylamide SCHEMBL17840598 0.82 ALDH1A1 (0.31) ALDH1A1
SCHEMBL25323636 0.81
SCHEMBL2175550 0.80
SCHEMBL1802297 0.80 TBXAS1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210171688-A1 BIOCOMPATIBLE COPOLYMER, CURABLE COMPOSITION, BIOCOMPATIBLE COATING LAYER AND BIOCOMPATIBLE DEVICE INCLUDING THE SAME NATIONAL CENTRAL UNIVERSITY (TW) 2021-06-10 US claimed
EP-2443486-B1 BIOMEDICAL DEVICES BAUSCH & LOMB (US) 2017-03-01 EP claimed
EP-2356497-A2 SILICONE HYDROGEL MATERIALS WITH CHEMICALLY BOUND WETTING AGENTS Novartis AG (CH) 2011-08-17 EP claimed
WO-2010056687-A2 SILICONE HYDROGEL MATERIALS WITH CHEMICALLY BOUND WETTING AGENTS NOVARTIS AG (CH) 2010-05-20 WO claimed
EP-2091979-A2 ACTINICALLY CURABLE SILICONE HYDROGEL COPOLYMERS AND USES THEREOF Novartis AG (CH) 2009-08-26 EP claimed
WO-2008076736-A2 ACTINICALLY CURABLE SILICONE HYDROGEL COPOLYMERS AND USES THEREOF NOVARTIS AG (CH) 2008-06-26 WO claimed
US-20210171688-A1 BIOCOMPATIBLE COPOLYMER, CURABLE COMPOSITION, BIOCOMPATIBLE COATING LAYER AND BIOCOMPATIBLE DEVICE INCLUDING THE SAME NATIONAL CENTRAL UNIVERSITY (TW) 2021-06-10 US disclosed
EP-3554811-A1 METHOD FOR PRODUCING CONTACT LENSES Novartis AG (CH) 2019-10-23 EP disclosed
WO-2018152395-A1 IONICALLY MODIFIED SILICONES, COMPOSITIONS, AND MEDICAL DEVICES FORMED THEREFROM MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2018-08-23 WO disclosed
WO-2018152392-A1 IONICALLY MODIFIED SILICONES, COMPOSITIONS, AND MEDICAL DEVICES FORMED THEREFROM MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2018-08-23 WO disclosed
EP-2791212-A1 HIGH IONIC STRENGTH PROCESS FOR CONTACT LENS MODIFICATION Semprus Biosciences Corp. (US) 2014-10-22 EP disclosed
EP-2791214-A1 REDOX PROCESSES FOR CONTACT LENS MODIFICATION Semprus Biosciences Corp. (US) 2014-10-22 EP disclosed
EP-2791223-A1 SURFACE MODIFIED CONTACT LENSES Semprus Biosciences Corp. (US) 2014-10-22 EP disclosed
WO-2010056687-A2 SILICONE HYDROGEL MATERIALS WITH CHEMICALLY BOUND WETTING AGENTS NOVARTIS AG (CH) 2010-05-20 WO disclosed
EP-2129513-A2 PREPOLYMERS WITH DANGLING POLYSILOXANE-CONTAINING POLYMER CHAINS Novartis Ag (CH) 2009-12-09 EP disclosed
WO-2009114490-A1 METHOD FOR CAST MOLDING CONTACT LENSES NOVARTIS AG (CH) 2009-09-17 WO disclosed
EP-2094235-A2 OCULAR DEVICES AND METHODS OF MAKING AND USING THEREOF Novartis AG (CH) 2009-09-02 EP disclosed
WO-2008116131-A2 PREPOLYMERS WITH DANGLING POLYSILOXANE-CONTAINING POLYMER CHAINS NOVARTIS AG (CH) 2008-09-25 WO disclosed
WO-2008073193-A2 OCULAR DEVICES AND METHODS OF MAKING AND USING THEREOF NOVARTIS AG (CH) 2008-06-19 WO disclosed
EP-0387706-A2 Oxygen permeable hard contact lens KURARAY CO., LTD. (JP) 1990-09-19 EP disclosed